Apimeds Pharmaceuticals Q4 EPS $(0.80) Down From $(0.50) YoY
Benzinga Newsdesk 6 months ago
EarningsNews
Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(0.80) per share. This is a 60 percent decrease over losses of $(0.50) per share from the same period last year.
Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(0.80) per share. This is a 60 percent decrease over losses of $(0.50) per share from the same period last year.